Summary of Quarterly Data (Unaudited)

12 Months Ended

Apr. 02, 2011

Summary of Quarterly Data [Abstract]


18.	SUMMARY OF QUARTERLY DATA (UNAUDITED)


	First		Second		Third		Fourth
	Quarter		Quarter		Quarter		Quarter

*Fiscal year ended April 2, 2011:*
Net revenues	$	163,039	$	166,833	$	176,789	$	170,033
Gross profit	$	86,463	$	87,755	$	93,490	$	87,501
Operating income	$	24,189	$	28,905	$	28,559	$	28,895
Net income	$	17,918	$	21,338	$	19,734	$	20,989
Share data:
Net Income:
Basic	$	0.71	$	0.86	$	0.79	$	0.82
Diluted	$	0.70	$	0.85	$	0.77	$	0.81
*Fiscal year ended April 3, 2010:*
Net revenues	$	154,087	$	157,070	$	165,169	$	169,104
Gross profit	$	82,943	$	80,967	$	85,447	$	88,124
Operating income	$	26,327	$	27,023	$	25,835	$	4,096
Net income	$	18,072	$	18,050	$	18,286	$	3,962
Share data:
Net Income:
Basic	$	0.70	$	0.70	$	0.72	$	0.16
Diluted	$	0.69	$	0.69	$	0.71	$	0.15

Gross profit declined during the fourth quarter of fiscal year 2011 due to a decline in sales volume and increased inventory reserves. Operating income remained flat during the same period due to a reduction in cash bonus incentive compensation as the Company’s financial results were lower than the financial targets established at the beginning of the year.

Operating income decreased by $21.7 million during the fourth quarter of fiscal year 2010 primarily due to:


	•	The impairment of two intangible assets totaling $15.7 million,

	•	Restructuring costs totaling $8.6 million, primarily separation benefits, associated with the integration of the Global Med Acquisition (under new accounting rules costs to separate employees of Global Med are now expensed), and the implementation of a customer solutions implementation group,

	•	Costs to consummate the acquisition of Global Med totaling $1.7 million,

partially offset by :


	•	Income totaling $2.3 million resulting from the remeasurement of the fair value of contingent consideration from our Neoteric acquisition.

- Definition

This element can be used to disclose the entire quarterly financial data disclosure in the annual financial statements as a single block of text. The disclosure includes a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished. Alternatively, the details of this disclosure can be reported using the elements in this group, or by using other taxonomy elements and applying the appropriate quarterly date and period contexts when creating an instance document. For example, the element for "Interest and Dividend Income, Operating" may be used by financial institutions from the Statement of Income, applying the appropriate quarterly date and period context when creating an instance document.

+ References+ Details